Dr Wei Phin Tan
Dr. Wei Phin Tan, MD, MHS is an assistant professor of urology and a urologic oncologist at Tisch Hospital, New York University Langone Health in New York City . He completed his urology residency at Rush University Medical Center and his urologic oncology fellowship at Duke University. He also completed a Masters of Health Science at Duke University.
Dr Tan’s research interest focuses on malignancies of the genitourinary system, with a particular emphasis on (i) prostate cancer diagnostics, (ii) focal therapy for prostate cancer and (iii) robotic assisted surgery (prostatectomies, nephrectomies, partial nephrectomies, cystectomies with intracorporeal reservoirs, retroperitoneal lymph node dissection).
Dr Tan has performed hundreds of transperineal procedures, including more than 200 transperineal MRI/US guided fusion biopsy under local anesthesia in 2023. He also regularly places fiducial markers and SpaceOARs/Barrigel under local anesthesia in the office. He also customizes prostate cancer treatment by performing focal therapy using cryoablation and high intensity focused ultrasound (HIFU) and patient directed prostatectomies.
Dr Tan has published more than 80 peer reviewed publications and delivered more than 100 international/national presentations to date. He was also previously funded by the Ruth L. Kirschstein National Research Service Award (NRSA) Grant from the National Cancer Institute (NCI).
Awards & Recognition
2024
World Chinese Urological Society WCUS Rising Star Award
2019
Best Oral Presentation of the Congress (Urological Association of Asia Congress- Kuala Lumpur, Malaysia)
2019
Best Short Oral Presentation- Runner up (Urological Association of Asia Congress- Kuala Lumpur, Malaysia)
2019
Best Poster Award (European Urological Association Meeting- Barcelona, Spain)
2016
Best Abstract Award (Rush University Medical Center Surgical Society 2016- Chicago, Il)
2015
Best Poster Presentation Award (Société Internationale d’Urologie 2015- Melbourne, Australia)
2015
Second Runner Up (Chicago Urological Society Imaging Contest 2015- Chicago, Illinois)
2013
Best Poster Presentation Award (Men’s Health World Congress 2013- Arlington, Virginia)
News
FOCAL THERAPY Use of Focal Therapy in Appropriate Candidates Discontinuing Active Surveillance: A Paradigm Shift
Prostate cancer is the second most common cancer in men globally, and its management remains a significant challenge. While localized low-grade prostate cancer has a long natural course and limited metastatic potential
Legislation Prioritizes Prostate Cancer Care for Veterans
A study conducted in 2013 by the Portland VA Medical Center and the Oregon Health and Science University suggested Agent Orange exposure was associated with a 52 percent increase in the overall risk of being diagnosed with prostate cancer.
RADIOLOGY CORNER: Left-sided Inferior Vena Cava and a Giant Renal Mass
Inferior vena cava (IVC) anatomical anomalies are rare, but of high importance in renal surgery. A left-sided IVC is the second most common anomaly of the IVC, and occurs in 0.2%-0.5% of the population.
Malaysian oncologist in US shares experience of getting Covid-19 vaccine
Public doubt over the safety of rapidly-developed Covid-19 vaccines have forced governments around the world to develop campaigns to assure their populace that these were not harmful or dangerous.
News
FOCAL THERAPY Use of Focal Therapy in Appropriate Candidates Discontinuing Active Surveillance: A Paradigm Shift
Prostate cancer is the second most common cancer in men globally, and its management remains a significant challenge. While localized low-grade prostate cancer has a long natural course and limited metastatic potential
Legislation Prioritizes Prostate Cancer Care for Veterans
A study conducted in 2013 by the Portland VA Medical Center and the Oregon Health and Science University suggested Agent Orange exposure was associated with a 52 percent increase in the overall risk of being diagnosed with prostate cancer.
RADIOLOGY CORNER: Left-sided Inferior Vena Cava and a Giant Renal Mass
Inferior vena cava (IVC) anatomical anomalies are rare, but of high importance in renal surgery. A left-sided IVC is the second most common anomaly of the IVC, and occurs in 0.2%-0.5% of the population.
Malaysian oncologist in US shares experience of getting Covid-19 vaccine
Public doubt over the safety of rapidly-developed Covid-19 vaccines have forced governments around the world to develop campaigns to assure their populace that these were not harmful or dangerous.
Make an Appointment
Select the time and date you prefer and book your appointment online.